Solidarity boosts peanut exports 10%

The leading destination markets abroad for the peanuts are Germany and Italy.

October 26, 2006 07:36


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Exports of peanuts from kibbutzim in the Ma'on region of the western Negev are expected to total 7,800 tons by the end of the year, 10 percent more than in 2005, Mifalei Hevel Ma'on said Wednesday, adding that the kibbutzim are expected to have earned "tens of millions of shekels" from the crop. The leading destination markets abroad for the peanuts are Germany and Italy. The success of peanut sales abroad is a good example of the advantage in concentrating agricultural exports "under one roof," said Mifalei Hevel Ma'on CEO Heshi Rubin. "If Israeli peanut exporters were to fight each other in the European markets, that would cause economic damage to all of them, as happens in some other agricultural sectors," he added.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection